Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance

Diabetologia

Volumn 58, Issue 4, 2015, Pages 799-808

  Kannt, Aimo ^a   Pfenninger, Anja ^a   Teichert, Lenore ^a   Tönjes, Anke ^b   Dietrich, Arne ^b   Schön, Michael R ^c   Klöting, Nora ^b   Blüher, Matthias ^b  

^a Sanofi Diabetes Global Medical Department   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

Author keywords

1 Methylnicotinamide; Adipose tissue; Insulin resistance; Nicotinamide; Nicotinamide N methyltransferase; NNMT; Type 2 diabetes

Indexed keywords

1 METHYLNICOTINAMIDE; GLIMEPIRIDE; INSULIN; MESSENGER RNA; METFORMIN; NICOTINAMIDE METHYLTRANSFERASE; PIOGLITAZONE; BIOLOGICAL MARKER; N(1)-METHYLNICOTINAMIDE; NICOTINAMIDE; NNMT PROTEIN, HUMAN;

ABDOMINAL SURGERY; ADULT; ARTICLE; BARIATRIC SURGERY; BODY WEIGHT; CONTROLLED STUDY; DIET THERAPY; EXERCISE; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; WHITE ADIPOSE TISSUE; AGED; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; ENZYMOLOGY; GENETICS; KINESIOTHERAPY; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; BARIATRIC SURGERY; BIOMARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EXERCISE THERAPY; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NIACINAMIDE; NICOTINAMIDE N-METHYLTRANSFERASE; OBESITY; RNA, MESSENGER; SUBCUTANEOUS FAT; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84925494663     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3490-7     Document Type: Article

References (29)

1. Haffner SM (2007) Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med 120:S10–S16
2. Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697–738
3. Blüher M (2009) Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 117:241–250
4. van Gaal LF, Mertens IL, de Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880
5. Chang AM, Smith MJ, Galecki AT, Bloem CJ, Halter JB (2006) Impaired beta-cell function in human aging: response to nicotinic acid-induced insulin resistance. J Clin Endocrinol Metab 91:3303–3309
6. Kahn SE, Beard JC, Schwartz MW et al (1989) Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 38:562–568
7. Greenbaum CJ, Kahn SE, Palmer JP (1996) Nicotinamide’s effects on glucose metabolism in subjects at risk for IDDM. Diabetes 45:1631–1634
8. HPS2-THRIVE collaborative group, Landray MJ, Haynes R et al (2014) Effects of extended-release niacin with laropiprant in high-risk patients. NEJM 371:203–212
9. Riederer M, Erwa W, Zimmermann R, Frank S, Zechner R (2009) Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine. Atherosclerosis 204:412–417
10. Kraus D, Yang Q, Kong D et al (2014) Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 508:258–264
11. Salek RM, Maguire ML, Bentley E et al (2007) A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 29:99–108
12. Harman-Boehm I, Blüher M et al (2007) Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 92:2240–2247
13. Blüher M, Williams CJ, Klöting N et al (2007) Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training. Diabetes Care 30:3110–3115
14. Chakaroun R, Raschpichler M, Klöting N et al (2012) Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 61:706–714
15. Blüher M, Unger R, Rassoul F, Richter V, Paschke R (2002) Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or type II diabetes. Diabetologia 45:210–216
16. Klöting N, Fasshauer M, Dietrich A et al (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299:E506–E515
17. Zhou SS, Li D, Sun WP et al (2009) Nicotinamide overload may play a role in the development of type-2 diabetes. World J Gastroenterol 15:5674–5684
18. Li D, Tian YJ, Guo J et al (2013) Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats. Br J Nutr 110:2156–2164
19. Jung JY, Kim IY, Kim YN et al (2012) 1H NMR-based metabolite profiling of diet-induced obesity in a mouse model. BMB Rep 45:419–424
20. Houstis N, Rosen ED, Lander ES (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440:944–948
21. Schmeisser K, Mansfeld J, Kuhlow D et al (2013) Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. Nat Chem Biol 9:693–700
22. Watanabe C, Seino Y, Miyahira H et al (2012) Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides. Diabetes 61:74–84
23. Yamada K, Miyazaki T, Hara N, Tsuchiya M (2010) Interferon-gamma elevates nicotinamide N-methyltransferase activity and nicotinamide level in human glioma cells. J Nutr Sci Vitaminol (Tokyo) 56:83–86
24. Ulanovskaya OA, Zuhl AM, Cravatt BF (2013) NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat Chem Biol 9:300–306
25. Tomida M, Mikami I, Takeuchi S, Nishimura H, Akiyama H (2009) Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. J Cancer Res Clin Oncol 135:1223–1229
26. Roessler M, Rollinger W, Palme S et al (2005) Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin Cancer Res 11:6550–6557
27. Sartini D, Muzzonigro G, Milanese G et al (2013) Upregulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: potential for the development of a urine-based diagnostic test. Cell Biochem Biophys 65:473–483
28. Tang SW (2011) Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells. Carcinogenesis 32:138–145
29. Sartini D, Pozzi V, Renzi E et al (2012) Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. Biol Chem 393:505–511